The stock's rise snapped a four-day losing streak.

Amid increasing economic tensions with the United States, China recently announced that it would ban Illumina, a U.S.-based company and the ...

Shares of Illumina Inc. ILMN rose 2.33% to $86.62 Friday, on what proved to be an all-around positive trading session for the ...

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Jazz Pharmaceuticals (JAZZ) and Illumina (ILMN). But which of these two stocks is more attractive to value ...

TD Cowen analyst Daniel Brennan maintained a Hold rating on Illumina (ILMN – Research Report) today and set a price target of $140.00. The ...

China banned the import of Illumina Inc. gene-sequencing machines as part of a wave of retaliatory measures against fresh US tariffs on all Chinese goods, deepening the US company’s woes in one ...

Illumina navigates competition and geopolitical risks with improved margins and strong cash flow. Read my analysis of ILMN ...

"Our new fiscal 2025 guidance provides for limited further earnings contribution from China, and assumes a continuation of the macro trends we see today," said Ankur Dhingra, CFO of Illumina. "We will ...

Illumina on Monday lowered its annual forecast and said it plans to cut $100 million in spending after China announced a ban on imports of its genetic sequencing instruments.

Piper Sandler analyst David Westenberg maintained a Buy rating on Illumina (ILMN – Research Report) today and set a price target of $190.00.

In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the other large-cap stocks. The big and large-cap stocks have spearheaded the rally in the past two ...